Scheduled maintenance - All access and functionalities will be impacted on Saturday, October 10th between 06h00 to 18h00 CET
Maintenance programmée - L'accès et toutes les fonctionnalités seront affectés samedi 10 octobre, entre 6 h 00 et 18 h 00 (CET)
Mantenimiento programado - El acceso y todas las funcionalidades se verán afectados el sábado 10 de octubre entre las 6h00 y las 18h00 CET

WCC 2020 Res 092 - Activity Report

Submitted by wenting.lei on Mon, 04/28/2025 - 11:24

General Information

Related Resolution / Recommendation
WCC 2020 Res 092
Period covered
IUCN Constituent
China Biodiversity Conservation and Green Development Foundation
IUCN Constituent type
IUCN Member organisation
Activities carried out to implement this Resolution
Relevant operative para(s) of Res/Rec Activities Overview Description Status
Policy influencing/advocacy
In March 2025, the Chinese National Medical Products Administration and the National Health Commission officially released the 2025 edition of the Pharmacopoeia of the People's Republic of China (Chinese Pharmacopoeia), which will take effect on October 1, 2025. Notably, 19 traditional Chinese medicines, including Gui Ling Ji, have been removed. Gui Ling Ji includes ingredients like pangolin and seahorse. Its removal from the Chinese Pharmacopoeia signifies that medicines containing pangolin will no longer be part of the national drug standards.
On-going
Actors involved in this resolution
IUCN Members IUCN Commissions IUCN Secretariat Other non-IUCN related organisations
Report status
Published
Constituent type
IUCN Member